CBS ProfEdu Resources
Written by: Erica Seelemann and Kaylee Brooks (CBS)
Canadian Blood Services supports best practices in transfusion medicine through the development of educational resources published on our Professional Education website. Written by subject-matter experts from across Canada, our transfusion medicine resources support clinical practice and help health-care professionals stay current in an ever-changing field.
These resources have the biggest impact when they’re read and shared! We invite you to explore and share our recent publications:
Clinical Guide to Transfusion: A practical summary of current transfusion medicine for healthcare professionals in Canada.
- Chapter 2. Blood components. This chapter revision provides an overview of blood component processing at Canadian Blood Services, including red blood cells, whole blood leukocytes reduced, platelets, plasma and cryoprecipitate. It also contains additional information on component dosing, indications/contraindications and alternatives.
- Chapter 3. Albumin. This chapter has recently been updated. The revised content outlines albumin efficacy, indications, contraindications, safety, dose and administration, storage and transportation, and alternative options.
- Chapter 21. An overview of donor wellness and perspectives. This new chapter provides an overview of various aspects of donor care and well-being, including a review of current knowledge on donor motivation, donation-related health impacts, adverse reactions and management.
Publications: Transfusion medicine resources to support clinical practice and help healthcare professionals stay up to date.
- Apheresis frozen plasma, psoralen-treated. This new publication provides information on apheresis frozen plasma, psoralen-treated, a blood group specific, pathogen-reduced human plasma for transfusion.
- FAQ: Apheresis frozen plasma, psoralen-treated. This publication provides answers to general, hospital technologist, and clinician questions regarding pathogen-reduced human plasma. This product will be available for transfusion in Canada beginning September 2025.
- FAQ: Whole blood, leukocytes reduced (LrWB) at Canadian Blood Services. This revision includes new information on the non-military use of whole blood for hospitals who are participating in clinical trials on whole blood, as well as a downloadable quick reference sheet designed for hospital staff participating in these trials.
- Summary of adverse transfusion reactions 2020-2025. This publication has recently been updated to include data from the 2024-2025 fiscal year.
If you don’t already receive our Research & Education Round Up, you can subscribe to the monthly newsletter here for updates on the latest news, publications, and events from Canadian Blood Services’ research and education network.